← Eichor
Study identifier: NCT06864884 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Phase 1 Study of ARC-001 in Participants Undergoing Third Molar Extraction

Condition: Acute Post Operative Pain · Third Molar Extraction Surgery  ·  Sponsor: Arcato Laboratories, Inc.

PhaseEARLY_Phase 1
Planned participants30
Who can joinAll sexes, 18 Years to 55 Years
Healthy volunteersNo

About this study

The study will test the investigational product gel against placebo (which contains no active ingredient) to determine if it is safe after wisdom tooth extraction. The main questions the study will answer are: 1. How much of the investigational product is absorbed in the blood? 2. Are there side effects?

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (1)

CenExel JBRSalt Lake City, Utah, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06864884